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Tuberculous pyomyositis is a rare clinical entity with serious consequences if a diagnosis is not established early. A 53-year-old
female with a past medical history of sarcoidosis and pulmonary fibrosis presented from an outside hospital with persistent fevers
and a rash. She had been hospitalized multiple times at an outside hospital without any improvement in her symptoms. On
examination, she was noted to have a large area of left upper lower extremity (LUE) tenderness with superimposed erythema.
Laboratory data revealed a white blood cell count of 22,300. Computed tomography (CT) scans of the LUE, chest, and left lower
extremity (LLE) showed multiple intramuscular abscesses in those regions without evidence of osteomyelitis. Subsequent drainage
of the abscesses and resulting cultures revealed Mycobacterium tuberculosis. The patient was started on therapy with rifampin,
isoniazid, pyrazinamide, and ethambutol. However, the patient developed hepatitis on these agents and subsequently went into
septic shock with multiorgan failure. Care was eventually withdrawn as a result of a poor prognosis. This case illustrates the severe
consequences of TB pyomyositis if not diagnosed promptly. While tuberculosis is uncommon in the United States, it should be an
important consideration in the differential diagnosis of immunocompromised patients.
1. Case Presentation
The patient is a 53-year-old Caucasian female with a history
of sarcoidosis and pulmonary fibrosis on chronic glucocorti-
coidswhopresentedtothehospitalwitha6–8monthhistory
of progressive pain, erythema, and edema on the left scapula,
biceps, and groin. The symptoms started with a burning
sensation over her left scapula. Her husband noted at the
time that she had a furuncular lesion in the area. Of note,
therewasnopriortraumatothearea.Thelesionsubsequently
progressed in size and pain, and she then developed fevers,
chills, and a home recorded temperature of 102
∘F. She also
progressed to left medial arm pain, swelling, and redness as
well as left leg erythema and pain. On review of systems,
s h ee n d o r s e ds u b j e c t i v ef e v e r s ,c h i l l s ,a n dn i g h ts w e a t s ;a
two-month history of blurry vision; baseline dyspnea on
supplemental oxygen use of 4 liters by nasal cannula; and
a recent sinus infection. She denied any cough, wheezes,
chest pain, palpitations, nausea, vomiting, abdominal pain,
or dysuria. She was hospitalized multiple times at an outside
hospital(OSH)whereshereceivedvancomycin,meropenem,
and doxycycline. Due to progression of her illness despite
treatment, she was subsequently transferred to our hospital.
Her past medical history included sarcoidosis and pul-
monaryfibrosisforwhichshewason10mgbidofprednisone
for about one year. Her only surgical history was a chole-
cystectomy. Her medications prior to admission included
fentanyl,prednisone,furosemide,fluoxetine,metoprolol,and
ferrous sulfate. Significant allergies included sulfa and peni-
cillins both of which caused hives. She had a 10-pack-year
history of tobacco use, but her last cigarette was 25 years ago.
Herpastoccupationwasasecretary,butshewasretiredatthe
time of presentation. She currently resides with her husband
in a house located in a wooded area of western Pennsylvania.
H e rt r a v e lh i s t o r yw a sa sf a rn o r t ha sN e wY o r ka n da sf a r
south as South Carolina. There was no recent travel history.
She has 3 pets: 2 dogs and 1 cat. There was no significant
family history of tuberculosis. It is unknown if she ever had a
tuberculin skin test.
On initial physical exam, the patient had a temper-
ature of 36.2
∘C, blood pressure of 110/62mmHg, pulse
of 78beats/min, respiratory rate of 18 breaths/min, and2 Case Reports in Medicine
Figure 1: Focal area of involvement on posterior chest wall.
Figure 2: Multiple abscesses in the left upper extremity and chest
wall.
an oxygen saturation of 98% on 4 liters of supplemental
nasal oxygen. She was toxic appearing, and in pain. Her
pupils were equal, round, and reactive to light. Extraocular
movements were also intact. The neck was supple, without
thyromegaly or jugular venous distension. Her lungs were
clear to auscultation bilaterally, and on cardiac exam, she
had regular heart sounds. The abdomen was soft, nontender,
nondistended, and without hepatosplenomegaly. On her left
upperback,shehadawell-definedboggyareaoftissuewhich
wasmildlyerythematousandtendertopalpation.Withinthe
boggy area was a 5mm hollow, circular ulceration without
fluctuance or purulence (Figure 1). On her left arm, she
had erythema, purpura, and induration which were painful
to palpation. On her LLE, she had 2+ pitting edema and
erythema extending from the groin to the foot. There was no
cervical, axillary, epitrochlear, or inguinal lymphadenopathy.
Initial laboratory values are summarized in Table 1.
2. Hospital Course
Thepatientwasadmittedtothegeneralmedicineserviceand
started on empiric broad spectrum antibiotics. CT scans of
the left arm and left leg revealed multiple subcutaneous and
intramuscular abscesses in the region of the left shoulder,
Table 1: Laboratory values at presentation to the outside hospital
and at presentation to our hospital.
Laboratory values Presentation to
OSH
Presentation to
our hospital
Sodium (136–146mMol/L) 122 133
Potassium (3.5–5mMol/L) 4.1 4.3
Chloride (98–107mMol/L) 80 93
Bicarbonate (21–31mMol/L) 33.3 31
BUN (8–26mg/dL) 16 12
Creatinine (0.5–1.4mg/dL) 0.79 0.8
Total protein (6.3–7.7g/dL) 5.6 4.7
Albumin (3.4–5g/dL) 2.4 2
Calcium (8.4–10.2mg/dL) 8.2
Total bilirubin (0.3–1.5mg/dL) 0.8 0.5
AST (15–41IU/L) 26 28
ALT (14–52IU/L) 36 23
Alkaline phosphatase
(38–126IU/L) 120 101
WBC (3.8–10.6 × 10
9/L) 22,300 12,100
Hemoglobin (11.6–14.6g/dL) 12.4 10.3
MCV (82.6–97.4fL) 86.2 85.3
Platelets (156–359 × 10
9/L) 406 295
ESR (0–40mm/hr) 39
CRP (<0.748mg/dL) 15.7
INR (0.8–1.2) 1.1
left arm, and left chest wall without evidence of osteomyelitis
(Figure 2).Alargeintramuscularabscessintheanteriorcom-
partment of the left thigh approximately 12cm in diameter
was also found. A subsequent CT of the chest, abdomen,
a n dp e l v i sd e m o n s t r a t e dg r o u n dg l a s so p a c i t i e si nt h er i g h t
u p pe rl u n ga n db ila t e r all o w e rl u n g s ,c e n tril o b ula rn od ul e s ,a
rightupperlobecalcifiedgranuloma,prominentparatracheal
and anteroposterior window lymph nodes, steatosis of the
liver, and parts of the fluid collections in the thigh as
noted above. She was started on empiric antibiotic therapy
with vancomycin, ceftriaxone, and metronidazole pending
drainage of the sample with cultures and sensitivities. She
then developed a rash on vancomycin and was switched to
linezolid.
Interventional radiology was consulted to biopsy the
affected areas. Multiple attempts were made in the back,
l e fta r m ,a n dl e fti n g u i n a lr e g i o nw i t ht h eo n l ys u c c e s s f u l
aspiration from the left inguinal region. The other sites failed
due to the thickness of the aspirate. The aspirate showed
acid-fast bacilli on smear and subsequently Mycobacterium
tuberculosis(MTB)onhospitalday14viaDNAprobe.Atthat
time, empiric antibiotics were stopped, and quadruple anti-
tuberculin therapy was initiated with isoniazid/pyridoxine,
rifampin, pyrazinamide, and ethambutol.
Concurrently, given the ground glass opacities and lack
o fc o u g ho rs p u t u mp r o d u c t i o nb yt h ep a t i e n t ,p u l m o n o l o g y
was consulted for bronchoscopy and bronchoalveolar lavageCase Reports in Medicine 3
(BAL) to rule out pulmonary tuberculosis. One month after
b r o n c h o s c o p y ,t h ec u l t u r ef r o mt h eB A Lt u r n e dp o s i t i v ef o r
MTB.
There were concerns about the patient’s potential wound
healing given the degree of tissue involved as well as chronic
steroid use. As a result, surgical debridement was deferred.
Unfortunately, on hospital day 28, the patient developed
elevated liver function tests (LFTs) necessitating cessation
of rifampin, isoniazid, and pyrazinamide. Moxifloxacin was
added as a second-line agent. Once her LFTs normal-
ized, rifampin was added. However, several days later, the
patient developed fevers and diarrhea. She was found to be
hypotensive with a systolic blood pressure in the 70s and
was transferred to the intensive care unit. She was started
on vasopressors for septic shock, intubated for respiratory
failure, and started on continuous renal replacement therapy
for acute kidney injury. Over the ensuing days, given her
overall poor prognosis, care was deescalated and the patient
died.
3. Discussion
Pyomyositisisapurulentinfectionofmusclethatisgenerally
theresultofhematogenousspread[1].Typically,theinfection
isknowntooccurinthetropicsinotherwisehealthyindivid-
ualswithnocomorbidities.Thoseafflictedinmoretemperate
regions tend to have severe underlying comorbidities or are
immunocompromised in some way [2].
The most common organisms implicated in pyomyositis
include Staphylococcus aureus as well as, increasingly,MRSA.
G r o u pAs t r e p t o c o c c ia r ea l s oc o m m o nw i t hg r a m - n e g a t i v e
bacilli and pneumococci, with non-group A streptococci
occurring less often [2]. There have also been instances of
mycobacterial-induced pyomyositis [3].
Typical presentations of pyomyositis involve fever and
painlocalizedtoamusclegroup,generallythelowerextremi-
ties[2].Theinfectionusuallyprogressesinthreestages.Stage
one tends to be characterized by fever, muscle pain, and
swelling. Since this is an early stage, an abscess may not yet
be apparent, and very few patients present at this stage. Stage
twoiswheremostpatientspresentandoccurs10–21daysafter
initial symptoms begin. It is characterized by fever, muscle
tenderness,andleukocytosis.Aspirationoftheareawillyield
purulent material. Finally, stage three is the most severe and
is accompanied by systemic toxicity. As a result, patients can
develop complications of bacteremia [4]. One study showed
a mortality rate that reached ten percent [5].
Diagnosis is typically made by radiography, predom-
inantly by CT, and culture data [6]. MRI may also be
helpful, especially in tuberculous pyomyositis [7, 8]. Because
pyomyositis arises from hematologic spread, cultures, both
from blood and drainage specimens, are extremely useful for
determining appropriate antibiotic use [1, 2].
Treatment is dependent on the stage of the disease with
stage 1 able to be treated by antibiotics. Stages 2-3 require
both drainage as well as antibiotic treatment. Drainage is
typically CT guided, but in the face of extensive disease,
surgical intervention may be a necessity [4].
Initial empiric antibiotic therapy is generally directed
against staphylococci and streptococci and typically includes
MRSA coverage in those who have previous infections, risk
factors, or systemic toxicity. If an individual is immuno-
compromised, antibiotic coverage should be broad, covering
gram positive and negative as well as anaerobic organisms [2,
4].Forsuspectedmycobacterialdisease,treatmentisthesame
as pulmonary tuberculosis. Duration of treatment is variable
depending on the complications and organisms involved,
with mycobacteria requiring longer treatment courses [9].
W h i l et u b e r c u l o s i si t s e l fi sc o m m o na r o u n dt h ew o r l d ,
extrapulmonary manifestations tend to be less common. A
studybyW angetal.in2003demonstratedthat1.8%ofculture
positive TB cases (21/1153) in Taiwan were TB myositis cases.
However, many of these cases had other manifestations of
TB, unlike our patient [3]. The difficulty of diagnosis in our
patient stems from her immunocompromised state and the
lackofothersymptomsoftuberculosis.Isolatedpresentations
o fT Ba sm y o s i t i sa r er a r ea n dn o tw i d e l yr e p o r t e di nt h e
literature.
4. Conclusion
Tuberculous pyomyositis should be considered in the differ-
ential diagnosis of immunosuppressed patients with fevers
and myalgias.
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